GlassScriptPhysician profile
Steven M Kaplan
NPI 1518073030
$6,278.84
in general payments reported to CMS, 2019-2025
40 companies · $505 in 2025
The $505 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $920 · 2020: $1,510 · 2021: $1,648 · 2022: $586 · 2023: $558 · 2024: $552 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,591 · Entertainment: $22.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,591.34 |
| Entertainment | $22.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,030.28 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $883.01 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Pfizer INC. | $485.25 | 2019-2023 | |
| Amarin Pharma, INC. | $427.65 | 2020-2021 | |
| Antares Pharma, INC. | $370.82 | 2019-2024 | Xyosted |
| Novo Nordisk INC | $339.03 | 2019-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $284.10 | 2019-2025 | Ofev, Jardiance |
| Lilly USA, LLC | $283.06 | 2019-2024 | Jardiance, Emgality, Mounjaro |
| Biohaven Pharmaceuticals, INC. | $249.41 | 2021 | |
| Allergan, INC. | $215.92 | 2019-2020 | |
| Bausch Health US, LLC | $183.93 | 2020-2021 | |
| Exact Sciences Corporation | $174.87 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $160.69 | 2019-2025 | Xifaxan |
| Biohaven Pharmaceutical Holding Company LTD. | $158.10 | 2022 | |
| Eisai INC. | $107.75 | 2020-2021 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kaplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.